Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.

@article{Cortegiani2016AntifungalAF,
  title={Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.},
  author={Andrea Cortegiani and Vincenzo Russotto and Alessandra Maggiore and Massimo Attanasio and Alessandro R Naro and Santi Maurizio Raineri and Antonino Giarratano},
  journal={The Cochrane database of systematic reviews},
  year={2016},
  volume={1},
  pages={
          CD004920
        }
}
BACKGROUND Invasive fungal infections are important causes of morbidity and mortality among critically ill patients. Early institution of antifungal therapy is pivotal for mortality reduction. Starting a targeted antifungal therapy after culture positivity and fungi identification requires a long time. Therefore, alternative strategies (globally defined as 'untargeted antifungal treatments') for antifungal therapy institution in patients without proven microbiological evidence of fungal… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 38 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 46 REFERENCES

Invasive Candidiasis.

  • The New England journal of medicine
  • 2015

Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain.

  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2014

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.

  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2012

Similar Papers

Loading similar papers…